Globus Medical
(NYSE) GMED
Globus Medical Financials at a Glance
Market Cap
$10.86B
Revenue (TTM)
$3.10B
Net Income (TTM)
$586.74M
EPS (TTM)
$4.29
P/E Ratio
18.64
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$82.74
Volume
45,248
Open
$80.91
Price
$82.74
Volume
45,248
Open
$80.91
Previous Close
$80.04
Daily Range
$80.91 - $83.57
52-Week Range
$51.79 - $101.40
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$82.74
Volume
45,248
Open
$80.91
Previous Close
$80.04
Daily Range
$80.91 - $83.57
52-Week Range
$51.79 - $101.40
Estimated Earnings Date
Aug 6, 2026
GMED News
Investing in Life Sciences Stocks
GMED: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Globus Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
6,000
CEO
Keith W. Pfeil, EMBA
Website
www.globusmedical.comHeadquarters
Audubon, PA 19403, US
GMED Financials
Key Financial Metrics (TTM)
Gross Margin
67.86%
Operating Margin
17.62%
Net Income Margin
18.92%
Return on Equity
13.04%
Return on Capital
10.23%
Return on Assets
10.79%
Earnings Yield
5.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.86B
Shares Outstanding
135.67M
Volume
45.25K
Avg. Volume
1.53M
Financials (TTM)
Gross Profit
$2.10B
Operating Income
$546.37M
EBITDA
$879.89M
Operating Cash Flow
$778.51M
Capital Expenditure
-$178.19M
Free Cash Flow
$600.32M
Cash & ST Invst.
$629.85M
Total Debt
$115.22M
Globus Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$759.85M
+27.0%
Gross Profit
$525.79M
+30.6%
Gross Margin
69.20%
N/A
Market Cap
$10.86B
N/A
Market Cap/Employee
$2.05M
N/A
Employees
5,300
N/A
Net Income
$124.30M
+64.7%
EBITDA
$226.93M
+38.3%
Quarterly Fundamentals
Total Cash
$629.85M
+36.5%
Total Debt
$115.22M
+24.8%
Accounts Receivable
$735.44M
+36.7%
Inventory
$772.60M
+16.4%
Long Term Debt
$100.10M
+22.5%
Short Term Debt
$15.12M
+42.4%
Return on Assets
10.79%
N/A
Return on Invested Capital
11.02%
N/A
Free Cash Flow
$162.75M
+19.5%
Operating Cash Flow
$202.36M
+14.1%